Active MRSA surveillance testing in about an hour
VRE: A growing concern
The rapid and continuous increase in the percentage of VRE carriage in the EU/EEA is a cause for concern.2
- Infections and deaths attributable to VRE almost doubled between 2007-20152
- The population-weighted mean percentage for VRE increased from 10.5% in 2015 to 17.3% in 20182
- High resistance levels have been reported from all regions in Europe2
- VRE has a significant impact on patient length of stay, and in turn, hospitalization costs3
VRE has become a substantive and growing burden in hospitalised patients, prompting the need for earlier and accurate detection.
Xpert vanA/vanB enables:
- Fast identification of VRE in around 45 minutes
- Laboratory efficiencies with on-demand workflows requiring minimal hands-on time, 24/7
- Timely infection control measures to reduce transmission and outbreaks, and enable appropriate use of isolation facilities
Fast and accurate PCR testing with Xpert®vanA/vanB greatly improves time to result, allowing healthcare professionals to quickly and appropriately manage patients, reducing transmission and enabling more efficient bed management.4
Optimize Workflow and Patient Management
- Deliver actionable results to clinicians and infection control teams in around 45 minutes
- On-demand STAT testing provides results 24/7
- Ease of use and minimal hands-on-time enables more efficient use of staff time
(1) Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Rest Infec Control. 2013 Nov;2(30).
(2) ECDC Surveillance Report. Surveillance of antimicrobial resistance in Europe 2018. Accessed Jun 2021. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018
(3) Hemapanpairoa J, et al. Does vancomycin resistance increase mortality? Clinical outcomes and predictive factors for mortality in patients with Enterococcus faecium infections. Antibiotics. 2021 Jan;10(2):105.
(4) Saliba R, et al. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci carriers? J Hosp Infect. 2019 Oct;103(2).
Number of Tests: 10Catalog #: GXVANA/B-CE-10
Number of Swabs: 50Catalog #: 900-0370